We established bronchioalveolar carcinoma NCI-H358 cell line and squamous cell carcinoma NCI-H520 cell line with a stable HSPA2 knockdown (Figure 3a and Figure S1a). This evidence concerns the gene HSPA2 and lung adenocarcinoma in situ.